Product Code Database
Example Keywords: science -mobile $48-152
   » » Wiki: Macfarlan Smith
Tag Wiki 'Macfarlan Smith'.
Tag

MacFarlan Smith is a pharmaceutical manufacturing company based in , Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners, Macfarlan Smith rebranded as . Veranova is a CDMO specialising in the development and manufacturing of specialist and complex active pharmaceutical ingredients, or APIs. It has facilities across Europe and North America.


Background

J.F. Macfarlan
J.F. Macfarlan Ltd was founded in 1780 as an supplier. In 1815 John Fletcher Macfarlan, licentiate of the Royal College of Surgeons, became the owner of the family business, and acquired an apothecary's shop in Edinburgh. He immediately began to manufacture , a medicine based on . In 1830 Macfarlan began a partnership with his former apprentice David Rennie Brown, and so incorporated the business as J.F. Macfarlan and Co Ltd. In 1832 the company began manufacture of the medicinal version of and , which led to the development and manufacture of the and . This allowed the company to develop sterile dressings for Joseph Lister, 1st Baron Lister under contract. After acquiring the Abbeyhill chemical works in 1840 for the production of , from 1870 the production of began in 1886. The company then acquired another site in Northfield, Edinburgh, in 1900 for the production of .


Duncan Flockhart
John Duncan was born in in 1780. After serving a five-year apprenticeship in Edinburgh, he moved directly to London, before returning to Perth in 1806 to establish a chemists shop.

After expanding to Edinburgh in 1820, Duncan dissolved the partnership with the Perth shop and started a new partnership in Edinburgh with William Flockhart (also from Kinross), which in 1833 was called Duncan & Flockhart, incorporated three years later. Following the death of John Duncan (c. 1839) the firm was taken over by his son Dr James Duncan. In the same year the firm began to manufacture , and from 1847 supplied to Sir James Simpson. The firm expanded, and supplied chloroform to both the , and British Red Cross during both world wars. After the start of World War I, the company established a drug growing farm at , to assure supply.


T&H Smith
T&H Smith was established as a at 21-23 Duke Street, Edinburgh in 1827, by Thomas Smith and his brother Henry.
(2003). 9780754633525, # Ashgate Publishing Limited.
On 13 April 1839, just three months after Henry Fox Talbot had announced his photogenic drawing process, T&H Smith placed an advert in offering photographic paper and chemicals. In 1840, the company bought a site in to the north of the city called Blandfield and moved their manufacturing operations here, the company developed the first of , later supplemented by creating various carbonated beverage flavours. Having opened a London branch in 1848, in 1851 the company discovered . But the company fortunes were made from 1855, when the first injection was developed. T&H Smith was the first company to produce commercial quantities of , and then in 1887. Between 1906 and 1908 the company moved from Canonmills to the suburban outskirts of Edinburgh at Gorgie, to a former brewery that they renamed "New Blandfield Works". During World War I, the company supplied Morphine and over of -based to the . In 1919, T&H Smith bought Glasgow Apothecaries. In 1926, the company acquired John Mackay Chemicals, subsequently incorporating its associated subsidiaries in , and .


Foundation
In 1962, T&H Smith bought Duncan Flockhart, and then merged with along J.F Macfarlan to form Edinburgh Pharmaceuticals. In 1965 the bought Edinburgh Pharmaceuticals, rebranding it Macfarlan Smith Ltd.

In 1958, while trying to develop dental anesthetic , the company had discovered the bitterest known substance, . Developed as a denaturant for industrial alcohol, in the 1970s it was commercially marketed as , a safety additive for household products such as liquid detergents. was the first supermarket to display the Bitrex brand on their products.

In 1963 the company reproduced highly potent , in a research group led by Professor Kenneth Bentley (Bentley compounds).Bentley KW, Hardy DG. "New potent analgesics in the morphine series." Proceedings of the Chemical Society. 1963;220.

Bought through a management buy out in 1990, Macfarlan Smith was floated on the London Stock Exchange in 1993 under the holding company Meconic, the word for .


Present
In June 2022, Johnson Matthey sold its Health division (including Macfarlan Smith) to Altaris Capital Partners. The company then rebranded as . Veranova is involved in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. With facilities in Europe, North America and Asia.

In 2001, plc bought Meconic, and merged it into its Fine Chemical and Catalysts division.

In late 2006, the British government permitted MacFarlan Smith to cultivate opium poppies in the United Kingdom for medicinal reasons, in response to increasing global prices for concentrate of poppy straw, the company's main raw material. A major opium poppy field is based in , England. As of 2012 they were growing in Dorset, Hampshire, Oxfordshire & Lincolnshire as a spring sown breakcrop recognised under the single payment scheme farm subsidy. The Office of Fair Trading has alerted the government to their monopoly position on growing in the UK and worldwide production of and recommended consideration. The government's response advocated the status quo, being concerned interference might cause the company to stop production.

The British government has since contradicted the 's suggestion that opium cultivation can be legalized in for exports to the United Kingdom, helping lower poverty and internal fighting whilst helping the National Health Service to meet the high demand for and . Opium poppy cultivation in the United Kingdom does not need a licence, but a licence is required for those wishing to extract opium for medicinal products.The painkilling fields: England's opium poppies that tackle the NHS morphine crisis, Press release , 15 September 2007.

Macfarlan Smith now claims to be one of the world's leading manufacturer of opiate alkaloids. Together with sister companies within the Johnson Matthey group, they can provide full spectrum drug development, from drug discovery through to bulk production.

Page 1 of 1
1
Page 1 of 1
1

Account

Social:
Pages:  ..   .. 
Items:  .. 

Navigation

General: Atom Feed Atom Feed  .. 
Help:  ..   .. 
Category:  ..   .. 
Media:  ..   .. 
Posts:  ..   ..   .. 

Statistics

Page:  .. 
Summary:  .. 
1 Tags
10/10 Page Rank
5 Page Refs